Clinical trial
Phase II Open Randomized Clinical & Health Economic Trial Comparing Intralesional Antimony Therapy Versus Wound Care Management in Old World Cutaneous Leishmaniasis Patients in Northern Afghanistan
NCT00996463 is registered in ClinicalTrials.gov with Waisenmedizin e. V. Promoting Access to Essential Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Open Randomized Clinical & Health Economic Trial Comparing Intralesional Antimony Therapy Versus Wound Care Management in Old World Cutaneous Leishmaniasis Patients in Northern Afghanistan
- Lead sponsor
- Waisenmedizin e. V. Promoting Access to Essential Medicine
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- March 31, 2011
- Enrollment
- 63 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
wound healing